Cargando…
miR186 suppresses prostate cancer progression by targeting Twist1
Prostate cancer (PCa) is the second leading cause of cancer-related deaths in north American men, and most its related deaths are due to advanced and metastatic PCa. However, the molecular mechanisms underlying PCa progression are still unclear. Here we use a pair of prostate cell lines P69/M12, whi...
Autores principales: | Zhao, Xian, Wang, Yanli, Deng, Rong, Zhang, Hailong, Dou, Jinzhuo, Yuan, Haihua, Hou, Guofang, Du, Yuzhang, Chen, Qin, Yu, Jianxiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078081/ https://www.ncbi.nlm.nih.gov/pubmed/27121312 http://dx.doi.org/10.18632/oncotarget.8887 |
Ejemplares similares
-
miR-186 Suppresses the Progression of Cholangiocarcinoma Cells Through Inhibition of Twist1
por: Zhang, Ming, et al.
Publicado: (2019) -
SUMOylation of TARBP2 regulates miRNA/siRNA efficiency
por: Chen, Cheng, et al.
Publicado: (2015) -
Twist1/Dnmt3a and miR186 establish a regulatory circuit that controls inflammation-associated prostate cancer progression
por: Zhao, X, et al.
Publicado: (2017) -
SUMO1 modification of KHSRP regulates tumorigenesis by preventing the TL-G-Rich miRNA biogenesis
por: Yuan, Haihua, et al.
Publicado: (2017) -
Acetylation of AGO2 promotes cancer progression by increasing oncogenic miR-19b biogenesis
por: Zhang, Hailong, et al.
Publicado: (2018)